Generic vs. brand-name cetrorelix for IVF ovarian stimulation
Part of Women’s health & pregnancy clinical trials.
This trial compares a generic version of cetrorelix acetate (a medication used to control ovulation) to the brand-name version during IVF. It aims to see if the generic works just as well for women undergoing ovarian stimulation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in a couple planning to have IVF or ICSI treatment.
- You are a woman under 43 years old.
- You are using a flexible GnRH antagonist protocol (your doctor will explain this).
- You are not planning preimplantation genetic testing (PGT).
- You do not have untreated hydrosalpinges, moderate/severe endometriosis, recurrent miscarriage, or untreated uterine problems.
- You do not have uncontrolled endocrine or other systemic diseases that could affect treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a half dose of the medication cetrorelix with the usual full dose during ICSI (a type of IVF) to see if the lower dose works as well with fewer side effects. It is for younger women with normal ovarian reserve and a higher BMI.
This study compares two methods of stimulating the ovaries before IVF: one using a standard hormone (hCG) and another using a different protocol. The goal is to see if the new method works as well as the standard one, while possibly being more cost-effective.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.
This trial tests a fixed dose of the hormone follitropin delta (Rekovelle) to stimulate the ovaries before intrauterine insemination (IUI). It aims to see if this approach works well for women with regular cycles who are starting IUI for the first time.
This study tests a one-time injection medicine (corifollitropin alfa) to help older women produce eggs for IVF. It aims to see if this medicine is safe and works well for women aged 36 to 40 with normal ovarian function.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.